Does comorbidity explain the ethnic inequalities in cervical cancer survival in New Zealand? A retrospective cohort study

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Brewer, Naomi ^a   Borman, Barry ^a   Sarfati, Diana ^b   Jeffreys, Mona ^c   Fleming, Steven T ^d   Cheng, Soo ^a   Pearce, Neil ^a,e  

^a MASSEY UNIVERSITY   (New Zealand)

^b UNIVERSITY OF OTAGO WELLINGTON   (New Zealand)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASIAN; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; ELIXHAUSER INSTRUMENT; ETHNIC DIFFERENCE; FEMALE; HAZARD RATIO; HOSPITAL EQUIPMENT; HUMAN; MAJOR CLINICAL STUDY; MAORI; NEW ZEALAND; RETROSPECTIVE STUDY; RISK REDUCTION; SCORING SYSTEM; UNITED STATES; UTERINE CERVIX CANCER; ABORIGINE; CANCER STAGING; ETHNOLOGY; HEALTH DISPARITY; MORTALITY; PATHOLOGY; STATISTICS; UTERINE CERVIX TUMOR;

COHORT STUDIES; COMORBIDITY; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; NEOPLASM STAGING; NEW ZEALAND; OCEANIC ANCESTRY GROUP; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 79953848315     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-132     Document Type: Article

References (42)

1. Ministry of Health Cancer. New Registrations and Deaths 2005. Revised edition 2009, Wellington, Ministry of Health.
2. The Descriptive Epidemiology Group of International Agency for Research on Cancer Globocan 2002 2002, Lyon, The Descriptive Epidemiology Group of International Agency for Research on Cancer.
3. Brewer N, Pearce N, Jeffreys M, White P, Ellison-Loschmann L. Demographic differences in stage at diagnosis and cervical cancer survival in New Zealand 1994-2005. J Women's Health (Larchmt) 2009, 18(7):955-963.
4. Brewer N, Pearce N, Jeffreys M, Borman B, Ellison-Loschmann L. Does screening history explain the ethnic differences in stage at diagnosis of cervical cancer in New Zealand?. Int J Epidemiol 2010, 39:156-165. 10.1093/ije/dyp303, 19808843.
5. Priest P, Sadler L, Sykes P, Marshall R, Peters J, Crengle S. Determinants of inequalities in cervical cancer stage at diagnosis and survival in New Zealand. Cancer Causes Control 2010, 21(2):209-214. 10.1007/s10552-009-9451-7, 19847659.
6. McLeod M, Harris R, Purdie G, Cormack D, Robson B. Improving survival disparities in cervical cancer between Māori and non-Māori women in New Zealand: a national retrospective cohort study. Aust N Z J Public Health 2010, 34(2):193-199.
7. Ministry of Health A portrait of health. Key results of the 2006/07 New Zealand Health Survey 2008, Wellington, Ministry of Health.
8. Robson B, Harris R, . (eds) Hauora: Māori Standards of Health IV. A study of the years 2000-2005 2007, Wellington: Te Rōpū Rangahau Hauora a Eru Pōmare, (eds).
9. Ministry of Health and Ministry of Pacific Island Affairs Tupu Ola Moui: Pacific Health Chart Book 2004 2004, Wellington, Ministry of Health and Ministry of Pacific Island Affairs.
10. Fleming ST, McDavid K, Pearce K, Pavlov D. Comorbidities and the risk of late-stage prostate cancer. TSW Urology 2006, 1:163-173.
11. Fleming S, Pursley H, Newman B, Pavlov D, Chen K. Comorbidity as a predictor of stage of illness for patients with breast cancer. Med Care 2005, 43(2):132-140. 10.1097/00005650-200502000-00006, 15655426.
12. Hill S, Sarfati D, Blakely T, Robson B, Purdie G, Chen J, Dennett E, Cormack D, Cunningham R, Dew K, McCreanor T, Kawachi I. Survival disparities in Indigenous and non-Indigenous New Zealanders with colon cancer: the role of patient comorbidity, treatment and health service factors. J Epidemiol Community Health 2010, 64:117-123. 10.1136/jech.2008.083816, 20056966.
13. Stevens W, Stevens G, Kolbe J, Cox B. Management of stages I and II non-small-cell lung cancer in a New Zealand study: divergence from international practice and recommendations. Intern Med J 2008, 38:758-768.
14. Davis P, Lay-Yee R, Fitzjohn J, Hider P, Schug S, Briant R, Scott A. Co-morbidity and health outcomes in three Auckland hospitals. NZ Med J 2002, 115:211-216.
15. Coker AL, Eggleston KS, Du XL, Ramondetta L. Ethnic disparities in cervical cancer survival among Medicare eligible women in a multiethnic population. Int J Gynecol Cancer 2009, 19(1):13-20. 10.1111/IGC.0b013e318197f343, 19258935.
16. D'Hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med 1993, 32:382-387.
17. Hopkins MP, Morley GW. Stage IB squamous cell cancer of the cervix: Clinicopathologic features related to survival. Am J Obstet Gynecol 1991, 164:1520-1529.
18. Peipert JF, Wells CK, Schwartz PE, Feinstein AR. Prognostic value of clinical variables in invasive cervical cancer. Obstet Gynecol 1994, 84:746-751.
19. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004, 291(20):2441-2447. 10.1001/jama.291.20.2441, 15161894.
20. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Impact of comorbidity on lung cancer survival. Int J Cancer 2003, 103:792-802. 10.1002/ijc.10882, 12516101.
21. van der Aa MA, Siesling S, Kruitwagen RFPM, Lybeert MLM, Coebergh JWW, Janssen-Heijnen MLG. Comorbidity and age affect treatment policy for cervical cancer: a population-based study in the south of the Netherlands, 1995-2004. Eur J Gynaecol Oncol 2008, 29(5):493-498.
22. New Zealand Department of Statistics Ethnicity in New Zealand: Recommendations for a standard classification. Discussion paper 1990, Wellington, New Zealand Department of Statistics.
23. Ministry of Health Cancer in New Zealand: Trends and Projections 2002, Wellington, Ministry of Health.
24. Ministry of Health Cancer Patient Survival Covering the Period 1994 to 2003 2006, Wellington, Ministry of Health.
25. Crampton P, Salmond C, Kirkpatrick R. Degrees of Deprivation in New Zealand. An atlas of socioeconomic difference 2004, Auckland: David Bateman Ltd, 2.
26. Statistics New Zealand Classification of urban area 2008, Wellington, Statistics New Zealand.
27. Benedet JL, Pecorelli S, Ngan HYS, Hacker NF, Denny L, Jones HW, Kavanagh J, Kitchener H, Kohorn E, Thomas G. Staging Classifications and Clinical Practice Guidelines for Gynaecological Cancers 2006, London: International Federation of Gynecology and Obstetrics.
28. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998, 36(1):8-27. 10.1097/00005650-199801000-00004, 9431328.
29. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383. 10.1016/0021-9681(87)90171-8, 3558716.
30. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J-C, Saunders LD, Beck CA, Feasby TE, Ghali A. Coding Algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005, 43(11):1130-1139. 10.1097/01.mlr.0000182534.19832.83, 16224307.
31. Preen DB, Holman CD, Spilsbury K, Semmens JB, Brameld KJ. Length of comorbidity lookback period affected regression model performance of administrative health data. J Clin Epidemiol 2006, 59:940-946. 10.1016/j.jclinepi.2005.12.013, 16895817.
32. Cox D. Regression models and life tables. J R Stat Soc 1972, 34:187-220.
33. Sarfati D, Blakely T, Pearce N. Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int J Epidemiol 2010, 39:598-610. 10.1093/ije/dyp392, 20142331.
34. New Zealand Health Information Service New Zealand Cancer Registry data dictionary 2004, Wellington, New Zealand Health Information Service.
35. Cormack D, Robson B, Purdie G, Ratima M, Brown R. Access to cancer services for Maori. A report prepared for the Ministry of Health 2005, Wellington: New Zealand Ministry of Health.
36. Ajwani S, Blakely T, Robson B, Atkinson J, Kiro C. Unlocking the numerator-denominator bias III: adjustment ratios by ethnicity for 1981-1999 mortality data. The New Zealand Census-Mortality Study. N Z Med J 2003, 116(1175):U456..
37. Sarfati D, Hill S, Purdie G, Dennett E, Blakely T. How well does routine hospitalisation data capture information on comorbidity in New Zealand?. NZ Med J 2010, 123(1310):50-61.
38. Leath CA, Straughn JM, Kirby TO, Huggins A, Partridge EE, Parham GP. Predictors of outcomes for women with cervical carcinoma. Gynecol Oncol 2005, 99(2):432-436. 10.1016/j.ygyno.2005.06.047, 16137753.
39. Minister of Health The New Zealand cancer control strategy 2003, Wellington, Minister of Health.
40. National Cervical Screening Programme Cervical Screening in New Zealand. A brief statistical review of the first decade 2005, Wellington: Ministry of Health, National Cervical Screening Programme.
41. Robson B, Purdie G, Cormack D. Unequal Impact: Maori and Non-Maori Cancer Statistics 1996-2001 2006, Wellington: Ministry of Health.
42. Jeffreys M, Stevanovic V, Tobias M, Lewis C, Ellison-Loschmann L, Pearce N, Blakely T. Ethnic inequalities in cancer survival in New Zealand: Linkage study. Am J Public Health 2005, 95(5):834-837. 10.2105/AJPH.2004.053678, 1449265, 15855462.